Mallinckrodt PLC (NYSE:MNK) – Equities research analysts at SunTrust Banks dropped their Q2 2019 earnings per share (EPS) estimates for shares of Mallinckrodt in a research note issued on Monday, May 13th. SunTrust Banks analyst G. Gilbert now anticipates that the company will post earnings per share of $2.06 for the quarter, down from their previous estimate of $2.07. SunTrust Banks currently has a “Hold” rating and a $20.00 price objective on the stock. SunTrust Banks also issued estimates for Mallinckrodt’s Q4 2019 earnings at $2.13 EPS and FY2020 earnings at $7.59 EPS.

Mallinckrodt (NYSE:MNK) last posted its earnings results on Tuesday, May 7th. The company reported $1.94 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.73 by $0.21. Mallinckrodt had a negative net margin of 118.53% and a positive return on equity of 14.22%. The business had revenue of $791.00 million for the quarter, compared to analyst estimates of $766.27 million. During the same quarter in the prior year, the firm posted $1.31 EPS. Mallinckrodt’s revenue was up 4.7% on a year-over-year basis.

MNK has been the subject of a number of other research reports. ValuEngine raised shares of Mallinckrodt from a “sell” rating to a “hold” rating in a research note on Monday, February 4th. Morgan Stanley set a $32.00 price objective on shares of Mallinckrodt and gave the stock a “hold” rating in a report on Thursday, February 28th. Mizuho increased their price target on shares of Mallinckrodt to $26.00 and gave the stock a “neutral” rating in a research note on Thursday, February 28th. Finally, Canaccord Genuity set a $40.00 price target on shares of Mallinckrodt and gave the stock a “buy” rating in a research note on Monday, March 18th. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. Mallinckrodt presently has an average rating of “Hold” and an average price target of $30.69.

MNK stock opened at $15.21 on Wednesday. Mallinckrodt has a one year low of $13.45 and a one year high of $36.65. The company has a market capitalization of $1.27 billion, a price-to-earnings ratio of 1.90, a P/E/G ratio of 0.15 and a beta of 2.12. The company has a debt-to-equity ratio of 1.90, a current ratio of 1.45 and a quick ratio of 1.08.

Several hedge funds and other institutional investors have recently made changes to their positions in MNK. CWM LLC boosted its holdings in shares of Mallinckrodt by 222.8% during the 1st quarter. CWM LLC now owns 1,159 shares of the company’s stock valued at $25,000 after acquiring an additional 800 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its holdings in shares of Mallinckrodt by 1,480.0% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 520,326 shares of the company’s stock valued at $33,000 after acquiring an additional 487,394 shares during the last quarter. FNY Investment Advisers LLC boosted its holdings in shares of Mallinckrodt by 210.4% during the 4th quarter. FNY Investment Advisers LLC now owns 2,288 shares of the company’s stock valued at $36,000 after acquiring an additional 1,551 shares during the last quarter. We Are One Seven LLC purchased a new stake in shares of Mallinckrodt during the 4th quarter valued at about $38,000. Finally, QS Investors LLC boosted its holdings in shares of Mallinckrodt by 14.3% during the 4th quarter. QS Investors LLC now owns 4,000 shares of the company’s stock valued at $64,000 after acquiring an additional 500 shares during the last quarter.

About Mallinckrodt

Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza.

Further Reading: Average Daily Trade Volume – ADTV

Earnings History and Estimates for Mallinckrodt (NYSE:MNK)

Receive News & Ratings for Mallinckrodt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mallinckrodt and related companies with MarketBeat.com's FREE daily email newsletter.